New York Genome Center, New York, NY.
Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI.
Genet Med. 2024 Jul;26(7):101137. doi: 10.1016/j.gim.2024.101137. Epub 2024 May 30.
Carrier screening has historically assessed a relatively small number of autosomal recessive and X-linked conditions selected based on frequency in a specific subpopulation and association with severe morbidity or mortality. Advances in genomic technologies enable simultaneous screening of individuals for several conditions. The American College of Medical Genetics and Genomics recently published a clinical practice resource that presents a framework when offering screening for autosomal recessive and X-linked conditions during pregnancy and preconception and recommends a tier-based approach when considering the number of conditions to screen for and their frequency within the US population in general. This laboratory technical standard aims to complement the practice resource and to put forth considerations for clinical laboratories and clinicians who offer preconception/prenatal carrier screening.
携带者筛查在历史上评估了相对较少的常染色体隐性和 X 连锁疾病,这些疾病是根据特定亚人群中的频率和与严重发病率或死亡率的关联选择的。基因组技术的进步使得同时对个体进行多种疾病的筛查成为可能。美国医学遗传学与基因组学学院最近发布了一份临床实践资源,提出了在妊娠和孕前筛查常染色体隐性和 X 连锁疾病时的框架,并建议在考虑要筛查的疾病数量及其在美国人群中的频率时采用基于层次的方法。本实验室技术标准旨在补充实践资源,并为提供孕前/产前携带者筛查的临床实验室和临床医生提供考虑因素。